BioTechX Sponsorship - Patient Advocacy 2022
BioTechX Sponsorship - Patient Advocacy 2022
BioTechX Sponsorship - Patient Advocacy 2022
BioTechX Sponsorship - Patient Advocacy 2022
BioTechX Sponsorship - Patient Advocacy 2022

BioTechX Sponsorship - Patient Advocacy 2022

Regular price $5,000.00 $0.00

CDH International is proud to be the Fiscal Sponsor for the Worldwide Rare Advocacy Partnership work at BioTechX 2022.  Join us as we support the patient voice at Europe's largest BioTech event!

 

Data. AI. Precision. Innovation.
For Pharma, Healthcare & Partners
8-10 November 2022 | Basel Congress Center, Switzerland


View the Conference Agenda Here.

 

300+ speakers This is a 4 in 1 world-class conference covers BioData World, Genomics Live, Cheminformatics Live & PharmAI. We're excited to announce there are 300+ world-class speakers now confirmed including Bayer, Novartis, Novo Nordisk, Sano Genetics, AstraZeneca and more.

 

To support the voice of patients at events, Terrapinn has generously agreed to give Rare Disease Patient Advocates a space at the event to engage industry leaders and open dialog between all players.  

Patient Advocates will be coming to the event from around the world, and unlike members of Industry, most do not have a travel budget.   This gives Industry the unique opportunity to direct support the Patient Voice by sponsoring the Patient Advocacy section of BioTechX.

 

Sponsorship Levels:

Level
Price
 Sponsorship Includes:

Silver

$5000

  • Name on signage at the event

  • Listed as sponsor on 1 presentation'

  • Panel Seat

    Gold

    $10,000

    • Logo on signage at the event

    • Listed as sponsor on 2  presentations

    • Panel Seat

    • 10 minute presentation (pertaining to Patient Advocacy)

      Platinum

      $25,000

      • Large logo on signage at the event

      • Listed as sponsor on 5 presentations

      • 2 Panel Seats

      • Vendor Table

      • 25 minute presentation (pertaining to Patient Advocacy)

        Diamond

        $50,000

        • Extra Large logo on signage at the event

        • Listed as sponsor on 10 presentations

        • Listed as room sponsor at event

        • 4 Panel Seats

        • Vendor Table

        • 50-minute presentation (pertaining to Patient Advocacy)

           

          After purchase, you will be contacted for details, company logo, statement, etc.   

          If you have any questions or would like to sponsor through CDH International's NGOs in Switzerland, the United Kingdom, the Netherlands, Singapore or Hong Kong, please email organizer, Dawn Ireland at dawn.ireland@cdhi.org

          ------------------------

          FOR IMMEDIATE RELEASE: BioTechX 2022 Congress Implements New Patient Advocacy Initiative

          FOR IMMEDIATE RELEASE: 

          BioTechX 2022 Congress Implements New Patient Advocacy Initiative 


          London, United Kingdom / Basel, Switzerland  – Tuesday, March 22, 2022 –  Patient advocates and rare disease nonprofits are overjoyed that the medical conference organizer, Terrapinn, has created a new platform to include patient voices. 


          “This November, BioTechX returns to Basel along with three co-located events. We are so excited to announce that this year BioTechX will take place alongside Genomics Live, PharmAI, and Cheminformatics Live. This is Europe's largest conference covering big data in pharmaceutical development and healthcare and will bring together thousands of industry leaders” announces Terrapinn on the company’s call for speakers. 


          Dawn Ireland attended her first Terrapinn event at the World Orphan Drug Congress in 2017 in Washington DC.  “I was so impressed that this company was so inclusive of patients and patient advocates.  Most industry events forget that patients are the consumers and should be the focus of all events.  Right away, I knew that I would be attending a lot of Terrapinn organized events” said Ireland, who is a patient advocate and president of CDH International, a global charity for Congenital Diaphragmatic Hernia patient support and research.  


          Ireland began speaking, chairing, and representing patients at Terrapinn’s BioData conference in Basel, Switzerland and World Evidence, Pricing and Access (EPA) Congress in Amsterdam.  In March of 2021, she secured a block of time for patient advocates at the EPA’s virtual event by tapping into her network of other advocates and her relationship with the Terrapinn team. 


          In November of 2021, the BioData Congress was back to an in-person event and had a great attendance but there was a lack of patient advocates.   She went to Chris Shanks, head of the EPA event and admin of the BioData, and asked for another block for patient advocates.   Shanks agreed and gave Ireland 3 hours.   


          Ireland took the project to the Worldwide Rare Advocacy Partnership (WRAP), a new collaboration she co-founded with 4 fellow patient advocates.   By the time the next meeting with Terrapinn was held, there were 15 well-known, well-respected patient advocates who were signed up to roll up their sleeves and bring Patient Advocacy to Terrapinn events in Europe. 


          “Sharing the rare patient voice at an international medical conference is so important to our patient groups. Patients and patient families want to be so much more than a number on a laboratory slide or a name on a registry. They want to be a real live human representation, not just their disease,” says Caryl Harris, co-founding partner at WRAP and Executive Director of Avery’s Hope, a patient assistance organization for the rare pediatric GI patient community. 


          Shanks responded by giving Ireland the WRAP team 3 days instead of 3 hours, and Terrapinn became the first company to officially incorporate an equal presence of Patient Advocacy at a medical industry event. 


          “Usually, medical conferences will give advocates and charities a discounted vendor booth, a few opportunities to speak at round tables or panels but Terrapinn has always shown Patient Advocacy as much respect as they show big Pharma and other Industry players.  They treat us as equals and that’s how every medical conference should be.  We are so grateful to them for leading the way in this important cause” says Ireland. 


          “Being able to share the human side to medical data gives researchers and medical teams an opportunity to see disorders and disease from a fully human perspective,” says Harris. 


          “I'm thrilled to finally see a conference organizer include the patient advocate voice on such a large scale. It's long overdue and perhaps the most important voice to hear. Thank you, Terrapin” says Terri Ellsworth, KOL Rare Disease Patient Advocate and the 3rd of 5 WRAP Co-Founding Partners. 

          In April, it was announced that BioData is now BioTechX and is 4 global events into one.

          Ireland and her partners at WRAP are looking for more Patient Advocacy leaders to speak at BioTechX as well as corporate sponsors to cover their costs to attend the event.  You can reach out to her at dawn.ireland@cdhi.org to participate.  


          BioTechX will take place on November 8-10th at the Basel Conference Center in Switzerland. 


          Learn more about the event at: https://www.terrapinn.com/conference/biodata/index.stm 


          Contact: 
          Dawn Ireland 
          dawn.ireland@cdhi.org 
          152 S White St 
          Wake Forest, NC 27587 
          (919) 610-0129 

           

          ------------------------------

          This event is fiscally sponsored by:


          A global initiative to stop Congenital Diaphragmatic Hernia

          CDH International United States  Registered 501(c)III #56-1916661
          CDH International Canada Registered c/o Chapel & York Foundation No. # 741095715 RR0001
          CDH International United Kingdom  Registered UK Charity no. 1189819
          CDH International Switzerland Registered by the Articles 60 et seq. of the Swiss Civil Code.
          CDH International Hong Kong  c/o Hong Kong Foundation for Charities Limited Registration Number 65159428-000
          CDH International Netherlands  c/o Stichting Chapel & York Foundation Netherlands | RSIN/Tax number: 858450215
          CDH International Singapore c/o Singapore Foundation for Charities Ltd | Registration Number 65159428-000

          More from this collection